CLL: Treatment and Management Strategies for Best Outcomes - Episode 9
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Related Content:
Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California
Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer
Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer
FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer